Page last updated: 2024-08-26

bosentan anhydrous and Hepatitis C

bosentan anhydrous has been researched along with Hepatitis C in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Descamps, D; Gervais, A; Larrouy, L; Le Beller, C; Lê, MP; Long, K; Mal, H; Papy, E; Peytavin, G	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Hepatitis C

Article	Year
Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:5 Topics: Antiviral Agents; Bosentan; Drug Interactions; Hepatitis B; Hepatitis C; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Oligopeptides; Sulfonamides	2013

Article

Year

Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.

The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:5

Topics: Antiviral Agents; Bosentan; Drug Interactions; Hepatitis B; Hepatitis C; HIV Infections; Humans; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Oligopeptides; Sulfonamides

2013